New mobile units to drive early breast cancer detection in Alberta
EDMONTON, Alberta, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Breast cancer screening is…
HKPC and GPTBots.ai: Joining Forces to Drive Intelligent Transformation for Hong Kong Enterprises
HONG KONG, Sept. 22, 2025 (GLOBE NEWSWIRE) -- GPTBots.ai, the enterprise AI…
Vocalbeats.AI Strengthens Commitment to AI Advancement as Sponsor of Singapores FutureChina Global Forum 2025
September 22, 2025 05:30 ET | Source: Vocalbeats FutureChina Global Forum 2025…
Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94%…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
Bravo Flowdex: How This Innovative Platform is Redefining AI Trading Read Bravo Flowdex Spain Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction –…
Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Multiple Myeloma Research Foundation (MMRF) Announces New Data from Flagship Research Initiatives at the 22nd International Myeloma Society Annual Meeting
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma…